Pfizer.com receives first makeover in three years

Share this article:
Pfizer has launched a refreshed consumer Web site featuring a cleaner design and new features.

“I think the site is warmer and more emotional in tone than the previous one, and it's reflective of what we've heard from our survey (of users),” Pfizer spokesman Andy McCormick told MM&M.
For Pfizer.com's first Web site makeover in nearly three years, the company worked with Grey unit G2 Direct and Digital to incorporate a product search on every single page.

“We've made it easier for our users to access our updated product information,” Pfizer spokeswoman Kate Bird added. “We've also incorporated a technology called Ajax, which is a combination of JavaScript and XML. That gives us the opportunity to highlight and promote certain events and programs without taking the user several clicks into the site.”

Other new Pfizer.com features include automated Securities and Exchange Commission filings and a more robust investor dashboard for Pfizer's investor population.

Also, a new R&D section features information on Pfizer's product pipeline as well as post-marketing commitments that are updated on a weekly basis.

Pfizer.com averages about 4 million visitors per year. That audience is comprised of both consumers and healthcare professionals, according to Bird.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.